Eczema and Genetics: Why Your DNA Shapes Your Skin

Eczema and Genetics: Why Your DNA Shapes Your Skin
By Jessica Arenas, Lead Research Analyst •

Twin studies reveal a striking truth about eczema and genetics: identical twins share the condition 72 to 86% of the time.[1][5] That number exceeds nearly every other skin condition. If you have eczema, your DNA played a major role in its development.[2]

You may have tried dozens of creams, changed your diet, switched your soap, and replaced your sheets. But the itch returns. That frustration makes sense. Eczema starts deep inside your cells, encoded in your genetic blueprint.[3] Understanding this can change how you approach treatment.

In this guide, you'll learn exactly which genes drive eczema risk, how your family history shapes your skin, and why genetics alone don't seal your fate. You'll also discover practical steps to manage genetically driven eczema. For a broader look at the five forces behind this condition, see our guide to the root causes of atopic dermatitis.

Scientists have identified over 30 genetic locations linked to atopic dermatitis. This opens new doors for targeted treatment.[4] The science is advancing rapidly—here's what it means for you.

Key Takeaways

  • Eczema has a 72 to 86% concordance rate in identical twins - genetics is the strongest single risk factor for developing atopic dermatitis.[5]
  • Filaggrin (FLG) gene mutations are found in many eczema patients. This gene controls your skin barrier's ability to hold moisture.[13]
  • Over 30 genetic locations have been linked to eczema risk. The condition is polygenic, meaning many genes contribute small effects.[4]
  • Genetics loads the gun, but environment pulls the trigger. Epigenetic changes mean your genes can be turned on or off by lifestyle factors.
  • You can manage genetic eczema effectively. Barrier repair, microbiome support, and targeted anti-inflammatory treatment address the root genetic defects.

Table of Contents

Bar chart showing eczema concordance rates in identical versus fraternal twins with 72-86% and 21-23% respectively

The link between eczema and genetics is one of the strongest in all of dermatology. Researchers have studied this connection for decades, and the evidence is compelling.

Twin Studies: The Strongest Proof

Twin studies give scientists a powerful way to separate genetic from environmental effects. Identical twins share 100% of their DNA. Fraternal twins share roughly 50%.[34]

When researchers compare eczema rates between the two groups, the difference is striking. Identical twins show a concordance rate of 72 to 86%.[1][5] Fraternal twins show only 21 to 23%.[1]

The bottom line: atopic dermatitis heritability is estimated at approximately 75% (with individual studies ranging from 69% to 86%), making it one of the most heritable complex diseases known.[5]

This means genetics explains why some people develop eczema and others don't. Your environment matters, but your DNA sets the stage.

Family Risk by the Numbers

Your family history reveals important patterns about your eczema risk.[6]

  • One parent with eczema: Your child has a 2 to 3 times higher risk of developing the condition.[6]
  • Both parents with eczema: The risk jumps to 3 to 5 times higher.[6]
  • Part of the atopic triad: Eczema often clusters with asthma and hay fever in families, a pattern called the "atopic march."[7]

Wondering what causes eczema in babies? Genetics is the biggest factor. Most children who develop eczema do so before age 5. Up to 85% of cases appear in the first five years of life.[8]

📚 Related Resource

Understanding your triggers alongside your genetics gives you the full picture. See our guide: What Causes Eczema Flare-Ups? 7 Triggers Backed by Science[35]

Cross-section diagram showing how filaggrin gene mutations affect the eczema skin barrier with labeled healthy versus compromised layers

The Filaggrin Gene: Your Skin Barrier's Blueprint

One gene stands out above all others linked to eczema. The filaggrin gene (FLG) is the most studied and most impactful genetic factor in atopic dermatitis.[9]

What Filaggrin Does

Filaggrin is a protein that acts like mortar between the bricks of your skin cells. It performs three critical jobs.

  • Binds skin cells together: Filaggrin aggregates keratin filaments in the outer skin layer, creating a tight, flat barrier.[9]
  • Locks in moisture: As filaggrin breaks down, it releases natural moisturizing factor (NMF) compounds that keep skin hydrated.[10]
  • Maintains acidic pH: Filaggrin breakdown products help keep skin slightly acidic, which blocks harmful bacteria.[11]

Without enough filaggrin, your skin can't perform these functions effectively. The result is dry, cracked, inflamed skin that lets allergens and irritants penetrate.

When Filaggrin Fails

About 8% of people in European populations carry at least one FLG mutation that reduces function.[12] Among people with moderate-to-severe eczema, that number rises considerably—studies report FLG mutations in roughly 20 to 45% of patients, depending on the population studied.[13]

What FLG mutations mean for your skin:

  • Reduced natural moisture: FLG mutations lower natural moisturizing factor (NMF) levels in the skin, contributing to dryness even in skin that appears uninflamed.[13]
  • Earlier onset: Children with FLG mutations tend to develop eczema earlier and have more severe disease.[3]
  • Higher allergy risk: FLG mutations increase the risk of food allergy and asthma, not just eczema.[14]
  • Persistent disease: People with FLG mutations are less likely to outgrow their eczema.[3]

Here's what matters most: many people with eczema don't carry FLG mutations.[13] Filaggrin is a major factor, but not the only one.

Process diagram showing the four categories of eczema genes: skin barrier genes, immune system genes, microbiome-related genes, and inflammation genes

Beyond Filaggrin: Other Eczema Genes

Large-scale genetic studies have identified over 30 genetic locations linked to atopic dermatitis.[4] These genes fall into two main categories: those affecting immune function and those affecting skin barrier integrity.

Immune System Genes

Your immune system plays a significant role in eczema. Several genes that control immune responses have been linked to the condition.

  • IL-4 and IL-13: These genes code for cytokines that drive the Th2 immune response. Overactivity of this pathway is a hallmark of eczema.[15]
  • CARD11: Mutations in this gene affect T-cell signaling and have been linked to severe atopic dermatitis.[16]
  • IL-31: This "itch cytokine" gene variant increases the intensity of eczema-related itching.[17]
  • TSLP: Thymic stromal lymphopoietin gene variants amplify the allergic immune response in the skin.[18]

These immune genes explain why eczema isn't just a skin problem. It's a body-wide immune condition that appears on your skin. Learn more about how immune dysfunction drives atopic dermatitis reactions.

Other Skin Barrier Genes

Beyond filaggrin, other genes help build and maintain your skin barrier.

  • KIF3A: This gene helps form the primary cilium on skin cells. Variants reduce skin barrier function and increase TEWL.[19]
  • SPINK5: Codes for a protease inhibitor that prevents premature breakdown of the skin barrier. Mutations lead to Netherton syndrome and eczema.[20]
  • Claudin-1: This tight junction protein gene shows reduced expression in eczema skin, allowing gaps between cells.[21]

The full picture is complex. Eczema involves dozens of genes working together, and no single gene causes it alone.

⚠️ Important Distinction:

Eczema is polygenic, not caused by a single gene. This means genetic testing for one gene (like FLG) cannot predict eczema with certainty.[4] Many genes each add a small amount of risk.

Is Eczema Inherited from Mom or Dad?

This is one of the most common questions parents ask, and the answer may surprise you.

Eczema does not follow a simple dominant or recessive pattern. It is a complex trait influenced by many genes from both parents.[2] Research has found some interesting patterns.

  • Maternal history matters more: Some studies suggest that maternal eczema carries a slightly higher risk for offspring than paternal eczema.[22]
  • Possible reasons: The maternal effect may relate to immune programming before birth, epigenetic imprinting, or shared early-life microbiome exposure.[23]
  • Both parents contribute: When both parents have atopic conditions, the risk is highest regardless of which parent has eczema specifically.[6]

You can't choose which genes you pass to your children, but knowing your family history helps you prepare. If eczema runs in your family, early moisturizing from birth may help protect your baby's skin barrier.[24]

Curious about whether eczema can spread? It can't—eczema is genetic, not contagious.

📚 Related Resource

Environmental factors interact with your genes to trigger flares. Learn how pollution affects eczema-prone skin: Can Air Quality Affect Eczema?

Comparison chart showing genetic versus environmental factors in eczema development with relative contribution percentages

Epigenetics: Why Your Genes Are Not Your Destiny

Here's the most hopeful part: your genes aren't fixed switches. They can be turned up, turned down, or silenced by your environment.

This field is called epigenetics, the study of how external factors change gene expression without altering the DNA sequence itself.[25]

Epigenetic factors that influence eczema genes:

  • DNA methylation: Chemical tags on DNA can silence eczema-related genes. Studies show altered methylation patterns in eczema patients.[26]
  • Histone modification: Changes to the proteins that package DNA affect which genes are active in skin cells.[25]
  • Environmental exposures: Pollution, tobacco smoke, and diet can all trigger epigenetic changes that increase eczema risk.[27]
  • Stress: Psychological stress alters gene expression in immune cells, potentially worsening eczema.[28]

What does this mean for you? Even if you carry eczema risk genes, your lifestyle choices can influence whether those genes activate. Managing stress and eczema together is one practical way to influence your epigenetic landscape.

This explains why identical twins don't always both develop eczema. Different life experiences create different epigenetic patterns, even with identical DNA.[25]

How Genetics Shapes Your Skin Microbiome

Your genes don't just affect your skin cells. They also shape the bacterial community living on your skin.

Research shows that FLG mutations change the skin's surface chemistry. This creates an environment that favors harmful bacteria like Staphylococcus aureus over beneficial species.[29]

  • S. aureus colonization: About 55% of eczema patients carry S. aureus on affected skin, compared to just 9% of healthy people.[30]
  • Reduced diversity: Eczema skin shows less microbial diversity, and this correlates with disease severity.[31]
  • Genetic influence: Your immune genes (like those controlling antimicrobial peptides) determine which bacteria can thrive on your skin.[29]

This is why treating eczema requires more than fighting inflammation. You also need to support a healthy skin microbiome. Learn more about the microbiome and eczema connection.

Products that address both inflammation and microbiome balance, like SmartLotion, take a dual approach. SmartLotion combines low-dose hydrocortisone with microbiome-supporting ingredients like sulfur and grapefruit seed extract to address both sides of the genetic equation.

Timeline showing expected improvement when managing genetic eczema with barrier repair and microbiome support over 8 weeks

Managing Eczema When Genetics Is the Root Cause

You cannot change your DNA, but you can work with it. Understanding the genetic basis of your eczema points you toward the most effective treatments.

  • Repair your skin barrier daily: Genetic eczema often involves barrier defects, so consistent moisturizing is essential. Apply emollients within three minutes of bathing to lock in moisture.[32] See our guide on adding moisture to your skin.
  • Support your microbiome: Choose products that don't strip beneficial bacteria. Avoid harsh soaps with sodium lauryl sulfate.[31]
  • Target inflammation wisely: Low-dose topical corticosteroids remain a first-line treatment. When used correctly, they are safe and effective for long-term management.[32] A well-formulated eczema cream can help you manage flares without overusing strong steroids.
  • Identify your personal triggers: Your genes set the baseline, but triggers cause flares. Track your exposures to find patterns.[33]
  • Consider early intervention for babies: If eczema runs in your family, daily emollient use from birth may reduce the risk by approximately 32% in high-risk infants.[24]

The goal is not to fight your genetics but to give your skin what your genes cannot provide on their own.

For a complete overview of treatment options from topicals to biologics, see our guide to atopic dermatitis treatments.

📚 Related Resource

Genetic eczema responds best to a multi-target approach. See our complete strategy guide: What Are the Root Causes of Atopic Dermatitis? 5 Factors[36]

Data visualization showing the relative contribution of key genetic factors to eczema risk including filaggrin, immune genes, and other barrier genes

Frequently Asked Questions About Eczema and Genetics

Is eczema dominant or recessive?

Eczema is neither purely dominant nor recessive. It is a complex polygenic condition, meaning many genes each contribute a small amount of risk.[2] Some specific mutations (like FLG) show a semi-dominant pattern, where carrying one copy increases risk and carrying two copies increases it further.[9]

Can genetic testing predict eczema?

Current genetic tests can identify FLG mutations, but they cannot predict eczema with certainty. Many people with FLG mutations never develop eczema, and many eczema patients do not carry FLG mutations.[4] Genetic testing is more useful for research than for individual prediction at this time.

Can you prevent eczema if it runs in your family?

You may be able to reduce the risk. Studies show that daily emollient use from birth in high-risk infants can lower eczema development by approximately 32%.[24] Breastfeeding and avoiding tobacco smoke exposure may also help.[27]

Will my child outgrow genetic eczema?

Many children do improve with age. Most children with eczema go into remission by adolescence or adulthood, with only about 10 to 30% continuing to experience symptoms.[8] However, children with FLG mutations and severe early-onset disease are less likely to outgrow it completely.[3]

Moving Forward with Genetic Knowledge

Understanding the link between eczema and genetics gives you power. Not the power to change your DNA, but the power to work with it.

Your genes explain why you have eczema, but they don't determine how well you manage it. With consistent barrier repair, microbiome support, and smart inflammation control, you can significantly reduce flares and improve your quality of life.

The science of eczema genetics is advancing rapidly, and new treatments targeting specific genetic pathways are in development. In the meantime, focus on what works now: protect your barrier, support your microbiome, and treat inflammation early.

You did not choose your genes, but you choose how you respond to them.

References

  1. Schultz Larsen F. "Atopic dermatitis: A genetic-epidemiologic study in a population-based twin sample." J Am Acad Dermatol. 1993;28(5):719-723. View Study
  2. Hoffjan S, Stemmler S. "Unravelling the complex genetic background of atopic dermatitis: from genetic association results towards novel therapeutic strategies." Archives of Dermatological Research. 2015. View Study
  3. Gupta J, Margolis DJ. "Filaggrin Gene Mutations with Special Reference to Atopic Dermatitis." Current Treatment Options in Allergy. 2020;7:403-413. View Study
  4. Paternoster L, et al. (EAGLE Eczema Consortium). "Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis." Nature Genetics. 2015;47(12):1449-1456. View Study
  5. Elmose C, Thomsen SF. "Twin Studies of Atopic Dermatitis: Interpretations and Applications in the Filaggrin Era." Journal of Allergy. 2015. View Study
  6. Uehara M, Kimura C. "Descendant family history of atopic dermatitis." Acta Dermato-Venereologica. 1993;73:62-63. View Study
  7. Zheng T, Yu J, Oh MH, Zhu Z. "The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma." Allergy, Asthma and Immunology Research. 2011;3(2):67-73. View Study
  8. Sánchez J, Ale IS, Angles MV, Fogelbach GG, Jansen AM, Takaoka R, Borzutzky A. "Healthcare Disparities in Atopic Dermatitis in Latin America: A Narrative Review." Dermatology and Therapy. 2023;13:399-416. View Study
  9. van den Oord RAHM, Sheikh A. "Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis." BMJ. 2009;339:b2433. View Study
  10. Tsukui K, Kakiuchi T, Suzuki M, Sakurai H, Tokudome Y. "The ion balance of Shotokuseki extract promotes filaggrin fragmentation and increases amino acid production and pyrrolidone carboxylic acid content in three-dimensional cultured human epidermis." Natural Products and Bioprospecting. 2022. View Study
  11. Choi EH, Kang H. "Importance of Stratum Corneum Acidification to Restore Skin Barrier Function in Eczematous Diseases." Annals of Dermatology. 2024. View Study
  12. Thyssen JP, Godoy-Gijon E, Elias PM. "Ichthyosis vulgaris: the filaggrin mutation disease." British Journal of Dermatology. 2013;168(6):1155-1166. View Study
  13. Moosbrugger-Martinz V, Leprince C, Méchin MC, Simon M, Blunder S, Gruber R, Dubrac S. "Revisiting the Roles of Filaggrin in Atopic Dermatitis." International Journal of Molecular Sciences. 2022;23(10):5318. View Study
  14. Tham EH, Leung DYM. "Mechanisms by Which Atopic Dermatitis Predisposes to Food Allergy and the Atopic March." Allergy Asthma Immunol Res. 2019;11(1):4-15. View Study
  15. Harb H, Chatila TA. "Mechanisms of Dupilumab." Clinical & Experimental Allergy. 2020;50(1):5-14. View Study
  16. Ma CA, Stinson JR, Zhang Y, et al. "Germline hypomorphic CARD11 mutations in severe atopic disease." Nature Genetics. 2017;49(8):1192-1201. View Study
  17. Mollanazar NK, Smith PK, Yosipovitch G. "Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?" Clinical Reviews in Allergy & Immunology. 2016;51:263-292. View Study
  18. Margolis DJ, Kim B, Apter AJ, Gupta J, Hoffstad O, Papadopoulos M, Mitra N. "Thymic Stromal Lymphopoietin Variation, Filaggrin Loss of Function, and the Persistence of Atopic Dermatitis." JAMA Dermatology. 2014;150(3):254-259. View Study
  19. Stevens ML, Zhang Z, Johansson E, et al. "Disease-associated KIF3A variants alter gene methylation and expression impacting skin barrier and atopic dermatitis risk." Nature Communications. 2020;11:4092. View Study
  20. Chavanas S, Bodemer C, Rochat A, et al. "Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome." Nature Genetics. 2000;25:141-142. View Study
  21. Yamada K, Matsushita K, Wang J, Kanekura T. "Topical Glucose Induces Claudin-1 and Filaggrin Expression in a Mouse Model of Atopic Dermatitis and in Keratinocyte Culture, Exerting Anti-inflammatory Effects by Repairing Skin Barrier Function." Acta Dermato Venereologica. 2018;98(1):19-25. View Study
  22. Vaughn AR, Sivamani RK, Lio PA, Shi VY. "Paternal vs. Maternal Factors in Childhood Atopic Dermatitis." Dermatitis. 2017;28(4):241-245. View Study
  23. Jenmalm MC. "The mother-offspring dyad: microbial transmission, immune interactions and allergy development." Journal of Internal Medicine. 2017;282(6):484-495. View Study
  24. Horimukai K, Morita K, Narita M, et al. "Application of moisturizer to neonates prevents development of atopic dermatitis." Journal of Allergy and Clinical Immunology. 2014;134(4):824-830. View Study
  25. Nedoszytko B, Reszka E, Gutowska-Owsiak D, et al. "Genetic and Epigenetic Aspects of Atopic Dermatitis." International Journal of Molecular Sciences. 2020;21(18):6484. View Study
  26. Kartal D, Dirican MH, Taheri S, Memiş M, Solak EÖ, Cinar SL, Borlu M. "Regulation of DNA methylation in lesional tissue of children with atopic dermatitis." Front Med. 2025;12:1531777. View Study
  27. Sobolev V, Bystritskaya E, Svitich O. "Epigenetic Studies of Atopic Dermatitis." Atopic Dermatitis - Essential Issues. 2021. View Study
  28. Suárez AL, Feramisco JD, Koo J, Steinhoff M. "Psychoneuroimmunology of Psychological Stress and Atopic Dermatitis: Pathophysiologic and Therapeutic Updates." Acta Dermato Venereologica. 2012;92(1):7-15. View Study
  29. Clausen M-L, Edslev SM, Andersen PS, Clemmensen K, Krogfelt KA, Agner T. "Staphylococcus aureus colonization in atopic eczema and its association with filaggrin gene mutations." British Journal of Dermatology. 2017;177(5):1394-1400. View Study
  30. Sangaphunchai P, Kritsanaviparkporn C, Treesirichod A. "Association Between Staphylococcus Aureus Colonization and Pediatric Atopic Dermatitis: A Systematic Review and Meta-Analysis." Indian Journal of Dermatology. 2023;68(6):619-627. View Study
  31. Clausen ML, Agner T, Lilje B, Edslev SM, Johannesen TB, Andersen PS. "Association of Disease Severity With Skin Microbiome and Filaggrin Gene Mutations in Adult Atopic Dermatitis." JAMA Dermatology. 2018;154(3):293-300. View Study
  32. Eichenfield LF, Tom WL, Berger TG, et al. "Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies." Journal of the American Academy of Dermatology. 2014;71(1):116-132. View Study
  33. Tamagawa-Mineoka R, Katoh N. "Atopic Dermatitis: Identification and Management of Complicating Factors." International Journal of Molecular Sciences. 2020;21(8):2671. View Study
  34. Beck JJ, Bruins S, Mbarek H, Davies GE, Boomsma DI. "Biology and Genetics of Dizygotic and Monozygotic Twinning." In: Khalil A, Lewi L, Lopriore E, editors. Twin and Higher-order Pregnancies. Springer; 2021. p. 31-50. View Study
  35. Langan SM, Williams HC. "What causes worsening of eczema? A systematic review." British Journal of Dermatology. 2006;155(3):504-514. View Study
  36. Kim J, Kim BE, Leung DYM. "Pathophysiology of atopic dermatitis: Clinical implications." Allergy and Asthma Proceedings. 2019;40(2):84-92. View Study

About the Author: Jessica Arenas, Lead Research Analyst

Jessica makes sense of the numbers behind skin health. With a background in biostatistics and clinical research, she translates complex genetic and dermatological studies into clear, actionable insights. When she's not diving into data, Jessica is passionate about community health education and volunteers at local health literacy programs.